Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record is now displayed with details about the pediatric cabozantinib study, including its termination after failing to meet accrual goals, study design, eligibility requirements, and outcome measures.
    Difference
    50%
    Check dated 2026-11-09T14:55:49.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:25:56.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:48:09.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The 403 error page now displays site revision v3.7.2 instead of v3.7.1; the page content and error state remain unchanged.
    Difference
    0.2%
    Check dated 2026-10-19T15:52:24.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:51:51.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error block from the page, which would display an access denial message. This suggests the page may now render the normal study details content instead of an error placeholder.
    Difference
    0.5%
    Check dated 2026-09-28T19:15:15.000Z thumbnail image

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.